logo
episode-header-image
Feb 2025
24m 12s

PTJ Author Interview: Randomized Clinica...

AMERICAN PHYSICAL THERAPY ASSOCIATION
About this episode

In this episode of the PTJ Podcast, Editor-in-Chief Steven George, PT, PhD, FAPTA, talks with Alexander Garbin, PT, DPT, PhD, and Jennifer Stevens-Lapsley, PT, PhD, FAPTA, about their recently published companion papers, which evaluated the effectiveness of a progressive multicomponent intervention for older adults in home health settings across three comparison groups. Listen as the authors discuss the pragmatic aspects of the trials, how the second study illustrates the importance of design and interpretation of control groups, and how early career researchers interested in conducting their own clinical trials can get started. 


Garbin and Stevens-Lapsley are co-authors of the articles “Progressive Multicomponent Intervention for Older Adults in Home Health Settings Following Hospitalization: Randomized Clinical Trial” and “Improving Function in Older Adults With Hospital-Associated Deconditioning: Lessons Learned Comparing a Randomized Controlled Trial to Real World Practice.” Read the articles on the PTJ  website and follow PTJ on  LinkedIn and Bluesky for more research updates.  

Up next
Oct 7
Accreditation Innovation: The Future of Physical Therapy Education
APTA is ushering in a historic change in physical therapy education: the merger of CAPTE and ABPTRFE into a single integrated accreditation body. This unification will streamline processes, reduce burdens on programs, and strengthen quality across the entire education continuum — ... Show More
26m 32s
Sep 30
PTJ Author Interview: Credentialism and the CAPTE 50 Percent Requirement
In this episode of the PTJ Podcast, Editor-in-Chief Steven George, PT, PhD, FAPTA, talks with Andrew Hogan, PhD, about his recently published perspective on the Commission on Accreditation in Physical Therapy Education standard requiring that at least 50% of core faculty in all p ... Show More
25m 30s
Sep 16
September Advocacy Roundup: How to Use APTA’s Direct Access Report
In this episode of the APTA Podcast, Justin Elliott, vice president of government affairs at APTA, and William Boissonnault, PT, DPT, DHSc, FAPTA, discuss APTA’s recent report on direct access to PT services. Boissonnault, a key contributor to the report, discusses the purpose of ... Show More
18m 59s
Recommended Episodes
Oct 2024
Older Patients With NSTEMI Randomized Interventional Treatment: SENIOR-RITA Trial
The goal of the SENIOR RITA trial was to evaluate routine invasive therapy compared with conservative therapy among older patients with non–ST-elevation myocardial infarction. Additionally, the trial assessed whether optimal medical therapy or coronary angiography and stents are ... Show More
6m 52s
Mar 2023
"The Problem with Clinical Trials" with Jonathan Shedler, PhD
Jonathan Shedler, Phd is a clinical professor of psychiatry at the University of California, San Francisco (UCSF) and faculty member at the San Francisco Center for Psychoanalysis. He is author of numerous scientific and scholarly articles, and his article The Efficacy of Psychod ... Show More
1h 5m
Jun 2025
#180 Beta-Blockers & REDUCE-AMI Trial: Beyond Journal Club Segment with NEJM Group
How much do beta blockers help after a heart attack, even when the heart’s pumping well? In this episode, we revisit the origins of beta blockers in post-MI care, examine how evidence evolved, and explore the REDUCE-AMI trial, which questions whether beta blockers are still neede ... Show More
26m 41s
May 2025
WARRIOR Trial: Outcomes to Reduce Events in Non-Obstructive Coronary Artery Disease
Funded by the Congressionally Directed Medical Research Programs (CDMRP) of the Department of Defense, the WARRIOR (Women's IschemiA TRial to Reduce events In non-ObstRuctive CAD) Trial addresses the urgent need for evidence-based care in a growing population of patients—particul ... Show More
10m 53s
Jun 2024
Movement for mental health with Professor Brendon Stubbs. EP#553
Mental Health problems are common and there is good evidence for physical activity as an important role to help prevent and treat mental health conditions. The BJSM has collaborated with the PACC programme to help develop this podcast and has invited Professor Brendon Stubbs, a g ... Show More
28m 43s
Apr 2025
Guidelines for the Diagnosis, Management, and Study of Autoimmune Retinopathy
In today’s episode, host Dr. Jay Sridhar is joined by Dr. Bobeck Modjtahedi to discuss the American Academy of Ophthalmology's new guidelines on autoimmune retinopathy (AIR), recently published in Ophthalmology Retina. A member of the Academy’s task force on AIR and lead author, ... Show More
27m 15s
Jun 2025
Updates in Amblyopia Treatment
Host Dr. Ben Young invites Drs. Roni Levin and Evan Silverstein to review the current state of amblyopia treatment, ranging from the mainstays of patching and atropine drops to novel advances such as dichoptic therapy. Below are some references regarding dichoptic therapy that we ... Show More
1 h
Jan 2025
#333 ‒ Longevity roundtable — the science of aging, geroprotective molecules, lifestyle interventions, challenges in research, and more | Steven Austad, Matt Kaeberlein, Richard Miller
View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter’s Weekly Newsletter In this special episode of The Drive, Peter introduces a brand-new roundtable format. Joined by three renowned experts in longevity science—Steven A ... Show More
2h 41m
Jun 2020
Covid-19 update: Cardiovascular disease, testing, social distancing and shielding, and dexamethasone
Kieran Walsh, clinical director at BMJ, asks editors from BMJ Learning and BMJ Best Practice to summarise the latest clinical guidance related to covid-19. Emma Scott discusses the latest guidance on cardiovascular disease. And Matt Castleden updates us on NHS Test and Trace, shi ... Show More
11m 12s
Sep 26
Sep 26 2025 This Week in Cardiology
A bold trial in valvular heart disease, a CV prevention trial whose message is humility, VTE dogma challenged, more news on oral GLP-1 agonists, and a few public service announcements are the topics John Mandrola, MD, discusses in this week’s podcast. This podcast is intended for ... Show More
22m 50s